Why did PRISMMEDI.BO stock jump today?

PRISMMEDI.BO stock rose on heavy trading and short-covering, with volume **13,238** well above average. The rally appears momentum-driven rather than news-driven, given no formal earnings release or broker updates.

What is Meyka AI’s view on PRISMMEDI.BO stock?

Meyka AI rates PRISMMEDI.BO **65.20** out of 100 (Grade B, HOLD). The platform flags momentum but notes mixed fundamentals and a yearly forecast of **INR 15.14**.

What short-term target and risk should traders use for PRISMMEDI.BO stock?

A short-term target of **INR 26.00** implies **15.15%** upside. We suggest stop-loss near **INR 18.00** because of limited liquidity and volatile price swings.

Are there valuation red flags in PRISMMEDI.BO stock fundamentals?

Yes. Reported EPS shows **-0.07** and an anomalous PE metric. Book value per share is **INR 24.89**, with PB **0.82**, indicating mixed signals between balance sheet strength and earnings volatility.

IN Stocks

PRISMMEDI.BO up 20.94% to INR 22.58 on BSE : short-term momentum meets valuation check

ByDanny Kontos February 20, 2026February 20, 2026

PRISMMEDI.BO stock jumped 20.94% to INR 22.58 at the BSE close on 20 Feb 2026. The move came on volume of 13,238 shares, nearly three times the average daily flow of 4,916. Intraday range was tight with open, low and high at INR 22.58, signaling aggressive buying at market open. We view this as a short-term momentum burst against mixed fundamentals and limited analyst coverage.